Screener by Innerkore

Shree Ganesh Remedies Limited

NSE: SGRLBSE: 540737HealthcarePharmaceuticals & Biotechnology

Shree Ganesh Remedies Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: SGRL and BSE: 540737 (ISIN INE414Y01015).

It has a market capitalisation of ₹886 crore, a last close of ₹690.10 on 2026-10-19.

Valuation: a price-to-earnings ratio of 49.85x, a price-to-book ratio of 5.43x, a dividend yield of 0.0%.

Profitability: return on equity of 11.5%, return on capital employed of 15.2%, an operating margin of 32.0%.

Growth: sales growth of 6.6% a year over three years, net profit growth of 1.5% a year over three years.

Balance sheet and ownership: debt-to-equity of 0.19x.

Key figures for SGRL, prices as of 2026-10-19
MetricValue
Market capitalisation886
Last close₹690.10
P/E (TTM)49.85x
P/B5.43x
Dividend yield0.0%
ROE (FY)11.5%
ROCE (FY)15.2%
Operating margin (TTM)32.0%
Sales growth, 3-year CAGR6.6%
Profit growth, 3-year CAGR1.5%
Debt / equity0.19x

Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means